
I rise today to recognize an extraordinary public servant who is leaving my office for a new role. Jon Donenberg has been one of my most trusted senior advisers since 2011, when I first ran for the U.S. Senate. After his stint advising me…
On the public record
Every politician on the site, every statement on file. Search, filter, and read the public record.
38,800+·quotes on file

I rise today to recognize an extraordinary public servant who is leaving my office for a new role. Jon Donenberg has been one of my most trusted senior advisers since 2011, when I first ran for the U.S. Senate. After his stint advising me…

We are the first generation to suffer from climate change, but the last generation which can do anything about it.

I can't support it, because the speaker is politicizing aid to Israel. He's politicizing our relationship. And fundamentally, politicizing our national security.

the GAO reported that private equity backed IRBs, I am going to quote here, 'are beholden to their clients or equity holders.'

I appreciate you raising this because I just want to make sure we get this right.

I have long described Federal support for medical research as one of the best investments that our Nation can make.

the GAO reported that private equity backed IRBs, I am going to quote here, 'are beholden to their clients or equity holders.'

I appreciate you raising this because I just want to make sure we get this right.

I have long described Federal support for medical research as one of the best investments that our Nation can make.

HHS and FDA need to step up their oversight efforts in this area.

I want to say again thank you to Senator Braun for holding this hearing.

For individuals who are experiencing a devastating diagnosis, the promise of a new therapy or a cure provides hope in a profoundly dark time.

The GAO reported that private equity backed IRBs, I am going to quote here, 'are beholden to their clients or equity holders.'

According to a recent GAO report, despite representing just two percent of the review boards, these commercial IRBs now review over half of studies involving investigational new drugs.

The GAO found that an emphasis on profits can lead private equity backed IRBs to rubber stamp reviews of drug clinical trials.

I appreciate you raising this because I just want to make sure we get this right.